• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性动机(欲望):当前治疗效果的临床前和临床评估存在的问题及解决方案。

Sexual Motivation (Desire): Problems with Current Preclinical and Clinical Evaluations of Treatment Effects and a Solution.

作者信息

Ågmo Anders

机构信息

Department of Psychology, University of Tromsø, 9037 Tromsø, Norway.

出版信息

Behav Sci (Basel). 2025 May 9;15(5):642. doi: 10.3390/bs15050642.

DOI:10.3390/bs15050642
PMID:40426419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12109267/
Abstract

There has been an extensive search for efficient pharmacological treatment of female sexual interest/arousal disorder and other sexual dysfunctions. However, available treatments have met limited success, except for the drugs used for treating erectile deficiency. A possible reason for this may be that both the preclinical and clinical evaluation of treatment effects have been inadequate. The present literature review shows that the intensity of sexual approach behaviors in non-human animals appears to be predictive of clinical effect whereas the traditional studies of copulatory behaviors and associated motor patterns have questionable predictive power regarding effects on human sexual desire. In clinical studies, it is essential to include the unconscious components of sexual motivation in any approach to its quantification. This basic fact is incompatible with the use of self-reports for evaluating treatment effects on motivation. Genital responses to sexual incentives are automatic and therefore outside of volitional control and can, therefore, provide unbiased estimates of the intensity of sexual motivation. These responses may be objectively quantified. Tests for implicit sexual motivation must also be used for capturing unconscious mental components. Including the unconscious components of sexual motivation as well as of objective measures of genital responses in clinical studies may improve evaluations of the effectiveness of drug treatment of low sexual interest/arousal disorder. In preclinical studies, predictive validity can be improved by quantifying sexual approach behaviors rather than copulatory behavior. The paradigm shift suggested here may finally allow for the discovery of efficient treatments for some sexual dysfunctions.

摘要

人们一直在广泛寻找治疗女性性兴趣/唤起障碍及其他性功能障碍的有效药物治疗方法。然而,除了用于治疗勃起功能障碍的药物外,现有治疗方法取得的成功有限。造成这种情况的一个可能原因可能是治疗效果的临床前和临床评估都不够充分。目前的文献综述表明,非人类动物的性接近行为强度似乎可以预测临床效果,而关于交配行为及相关运动模式的传统研究对人类性欲影响的预测能力则存在疑问。在临床研究中,在任何量化性动机的方法中纳入性动机的无意识成分至关重要。这一基本事实与使用自我报告来评估治疗对动机的效果不相容。对性刺激的生殖器反应是自动的,因此不受意志控制,因此可以提供对性动机强度的无偏估计。这些反应可以客观量化。还必须使用内隐性性动机测试来捕捉无意识的心理成分。在临床研究中纳入性动机的无意识成分以及生殖器反应的客观测量方法,可能会改善对低性兴趣/唤起障碍药物治疗效果的评估。在临床前研究中,通过量化性接近行为而非交配行为可以提高预测效度。这里提出的范式转变最终可能会促成一些性功能障碍有效治疗方法的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4f/12109267/a57528615763/behavsci-15-00642-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4f/12109267/d2d3108cc0d1/behavsci-15-00642-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4f/12109267/653a7a0d29ba/behavsci-15-00642-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4f/12109267/a57528615763/behavsci-15-00642-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4f/12109267/d2d3108cc0d1/behavsci-15-00642-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4f/12109267/653a7a0d29ba/behavsci-15-00642-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4f/12109267/a57528615763/behavsci-15-00642-g003.jpg

相似文献

1
Sexual Motivation (Desire): Problems with Current Preclinical and Clinical Evaluations of Treatment Effects and a Solution.性动机(欲望):当前治疗效果的临床前和临床评估存在的问题及解决方案。
Behav Sci (Basel). 2025 May 9;15(5):642. doi: 10.3390/bs15050642.
2
Animal models of female sexual dysfunction: basic considerations on drugs, arousal, motivation and behavior.女性性功能障碍的动物模型:关于药物、唤起、动机和行为的基本考量
Pharmacol Biochem Behav. 2014 Jun;121:3-15. doi: 10.1016/j.pbb.2013.10.003. Epub 2013 Oct 11.
3
Electroencephalographic activity during sexual behavior: a novel approach to the analysis of drug effects on arousal and motivation relevant for sexual dysfunctions.性行为期间的脑电图活动:一种分析药物对与性功能障碍相关的唤醒和动机影响的新方法。
Pharmacol Biochem Behav. 2014 Jun;121:158-69. doi: 10.1016/j.pbb.2014.02.003. Epub 2014 Feb 14.
4
Sex Differences in Sexual Motivation in Humans and Other Mammals: The Role of Conscious and Unconscious Processes.人类和其他哺乳动物性动机中的性别差异:意识与无意识过程的作用。
Behav Sci (Basel). 2024 Mar 27;14(4):277. doi: 10.3390/bs14040277.
5
Implicit Measures in Clinical Sex Research: A Critical Evaluation.临床性研究中的内隐测量:批判性评价。
Sex Med Rev. 2020 Oct;8(4):531-541. doi: 10.1016/j.sxmr.2020.06.005. Epub 2020 Aug 5.
6
Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part III.朝着更具循证医学的女性性功能障碍分类学和命名法迈进——第三部分。
J Sex Med. 2019 Mar;16(3):452-462. doi: 10.1016/j.jsxm.2019.01.010.
7
Animal Models for the Study of Female Sexual Dysfunction.用于研究女性性功能障碍的动物模型
Sex Med Rev. 2013 Jul;1(2):108-122. doi: 10.1002/smrj.14. Epub 2015 Oct 18.
8
Preclinical models of sexual desire: conceptual and behavioral analyses.性欲的临床前模型:概念与行为分析
Pharmacol Biochem Behav. 2004 Jul;78(3):379-404. doi: 10.1016/j.pbb.2004.04.013.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part II.迈向更具循证性的女性性功能障碍疾病分类学与命名法——第二部分。
J Sex Med. 2016 Dec;13(12):1888-1906. doi: 10.1016/j.jsxm.2016.09.020. Epub 2016 Nov 11.

本文引用的文献

1
Automatic implicit motive codings are at least as accurate as humans' and 99% faster.自动内隐动机编码至少与人类编码一样准确,且速度快99%。
J Pers Soc Psychol. 2025 Jun;128(6):1371-1392. doi: 10.1037/pspp0000544. Epub 2025 Apr 10.
2
Female Syrian hamster analyses of bremelanotide, a US FDA approved drug for the treatment of female hypoactive sexual desire disorder.对布雷美拉诺肽的雌性叙利亚仓鼠分析,布雷美拉诺肽是一种经美国食品药品监督管理局批准用于治疗女性性欲减退障碍的药物。
Neuropharmacology. 2025 Apr 1;267:110299. doi: 10.1016/j.neuropharm.2025.110299. Epub 2025 Jan 9.
3
Sexual Dysfunction in Women.
女性性功能障碍
N Engl J Med. 2024 Aug 22;391(8):736-745. doi: 10.1056/NEJMcp2313307.
4
Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis.氟班色林治疗女性性欲低下障碍的作用:系统评价和荟萃分析。
Medicine (Baltimore). 2024 Jun 21;103(25):e38592. doi: 10.1097/MD.0000000000038592.
5
Sex Differences in Sexual Motivation in Humans and Other Mammals: The Role of Conscious and Unconscious Processes.人类和其他哺乳动物性动机中的性别差异:意识与无意识过程的作用。
Behav Sci (Basel). 2024 Mar 27;14(4):277. doi: 10.3390/bs14040277.
6
Automatic Associations between Sexual Function Problems and Pursuing Help in Pelvic Physical Therapy Practice: The Psychometric Investigation of an Implicit Association Test.性功能问题与寻求盆腔物理治疗帮助之间的自动关联:内隐联想测验的心理测量学研究。
J Sex Marital Ther. 2024;50(5):627-637. doi: 10.1080/0092623X.2024.2344607. Epub 2024 Apr 23.
7
Genital arousal and responsive desire among women with and without sexual interest/arousal disorder symptoms.有和没有性兴趣/唤起障碍症状的女性的生殖器唤起和反应性欲望。
J Sex Med. 2024 May 28;21(6):539-547. doi: 10.1093/jsxmed/qdae036.
8
Conceptualizing Sexual Wellbeing: A Qualitative Investigation to Inform Development of a Measure (Natsal-SW).性健康的概念化:一项为性健康测量工具(Natsal-SW)开发提供信息的定性研究
J Sex Res. 2025 May-Jun;62(5):693-711. doi: 10.1080/00224499.2024.2326933. Epub 2024 Mar 22.
9
In search of animal normativity: a framework for studying social norms in non-human animals.探索动物规范性:研究非人类动物社会规范的框架。
Biol Rev Camb Philos Soc. 2024 Jun;99(3):1058-1074. doi: 10.1111/brv.13056. Epub 2024 Jan 24.
10
The elusive concept of sexual motivation: can it be anchored in the nervous system?难以捉摸的性动机概念:它能在神经系统中找到根源吗?
Front Neurosci. 2023 Nov 17;17:1285810. doi: 10.3389/fnins.2023.1285810. eCollection 2023.